Cheng-da Hsu
Jiayi Shi, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Cyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3β to suppress mTOR and β-catenin signaling pathways.
Journal: Cancer letters
Published: June 02, 2015
Guizhi Fuling Wan as a Novel Agent for Intravesical Treatment for Bladder Cancer in a Mouse Model.
Journal: Molecular medicine (Cambridge, Mass.)
Published: April 12, 2015
Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.
Journal: Oncotarget
Published: April 03, 2015
Distal 10q trisomy with copy number gain in chromosome region 10q23.1-10q25.1: the Wnt signaling pathway is the most pertinent to the gene content in the region of copy number gain: a case report.
Journal: BMC research notes
Published: August 01, 2014
Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase.
Journal: BMC cancer
Published: April 19, 2014
Sequence variants of the HTR3A gene contribute to the genetic prediction of postoperative nausea in Taiwan.
Journal: Journal of human genetics
Published: March 27, 2014
Age-dependent association between Dickkopf-1 and calcium-containing urolithiasis.
Journal: Urology
Published: October 24, 2013
Clinical significance of survivin expression in patients with urothelial carcinoma.
Journal: Disease markers
Published: October 20, 2013
Cortex Moutan Induces Bladder Cancer Cell Death via Apoptosis and Retards Tumor Growth in Mouse Bladders.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: March 28, 2013
Unexpected remission of hepatocellular carcinoma (HCC) with lung metastasis to the combination therapy of thalidomide and cyproheptadine: report of two cases and a preliminary HCC cell line study.
Journal: BMJ case reports
Published: October 19, 2012
The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder.
Journal: BMC complementary and alternative medicine
Published: May 16, 2012
The high incidence of JC virus infection in urothelial carcinoma tissue in Taiwan.
Journal: Journal of medical virology
Published: October 21, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026